Investing Show: What next for drug company shares?
Richard Hunter, market strategist, takes a look at the big FTSE 100 drug companies, their dividends and whether poor sentiment in recent times makes them a decent prospect now.
Published by Associated Newspapers Ltd
Part of the Daily Mail, The Mail on Sunday & Metro Media Group
© Associated Newspapers Ltd Contact us How to complain Advertise with us Contributors Work with Us Terms Privacy policy & cookies
|
|
||